http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. http://www.physorg.com/news176963676.html Medicine & Health Mon, 09 Nov 2009 04:50:04 EST news176963676 Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone, according to a Radiation Therapy Oncology Group (RTOG) study, the largest randomized trial of its kind, presented November 2, 2009, at the American Society for Radiation Oncology (ASTRO) annual meeting. The RTOG trial noted that this benefit appeared to be greatest for men currently defined as at medium-risk for disease failure. http://www.physorg.com/news176387429.html Medicine & Health Mon, 02 Nov 2009 12:30:53 EST news176387429 Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women. However, the 2002 publication of a major study, the Women's Health Initiative (WHI), indicated increased risk for certain outcomes in older women, without increasing mortality. This sparked debate regarding potential benefits or harm of HRT. http://www.physorg.com/news175965554.html Medicine & Health Wed, 28 Oct 2009 16:40:02 EST news175965554 (AP) -- What to do if menopause makes you miserable? http://www.physorg.com/news175747695.html Medicine & Health Mon, 26 Oct 2009 03:49:28 EST news175747695 (AP) -- Miserable in menopause, Elizabeth Alsgaard pondered an awful choice: Drenching hot flashes or hormone therapies that might raise the risk of cancer. What former actress Suzanne Somers raved about held much more appeal - custom-mixed "bioidentical" hormones, just like ones the body makes. http://www.physorg.com/news175692842.html Medicine & Health Sun, 25 Oct 2009 12:50:05 EST news175692842 The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk, Yale researchers report in an abstract presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21. http://www.physorg.com/news175190615.html Medicine & Health Mon, 19 Oct 2009 17:40:05 EST news175190615 New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems. Some choices of therapy appear, however, to be less risky than others. http://www.physorg.com/news172819508.html Medicine & Health Tue, 22 Sep 2009 16:30:02 EST news172819508 (AP) -- A new study links hormone therapy for prostate cancer with a higher risk of death in older men who've had serious heart problems. http://www.physorg.com/news170440583.html Medicine & Health Tue, 25 Aug 2009 18:00:03 EST news170440583 Scientists at Michigan State University have found exposure to the hormone progesterone activates genes that trigger inflammation in the mammary gland. http://www.physorg.com/news169908140.html Biology Wed, 19 Aug 2009 13:42:35 EST news169908140 Two studies conducted by researchers at the University of Illinois at Chicago and Northwestern University have found that commonly used botanicals do not have an effect on hot flashes or on cognitive function in menopausal women. http://www.physorg.com/news168857939.html Medicine & Health Fri, 07 Aug 2009 10:10:01 EST news168857939 Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis. http://www.physorg.com/news165748182.html Medicine & Health Thu, 02 Jul 2009 10:10:15 EST news165748182 The recent decline in invasive breast cancer in the US was significantly less pronounced in the poor and those who live in rural areas. Researchers writing in the open access journal BMC Medicine suggest this may be due to varying reductions in the numbers of women taking hormone therapy (HT). http://www.physorg.com/news165217868.html Medicine & Health Fri, 26 Jun 2009 07:30:01 EST news165217868 Some women take a short break from using postmenopausal hormone therapy before getting their breasts screened for cancer with mammography. They hope to lower their risk of being called back afterward for unnecessary extra breast imaging. But taking a short break from hormones doesn't actually work for this purpose, according to the first large-scale randomized controlled trial to address the question. The READ (Radiological Evaluation and Breast Density) trial of more than 1,700 Group Health women is in the June 2, 2009 Annals of Internal Medicine. http://www.physorg.com/news163095683.html Medicine & Health Mon, 01 Jun 2009 17:21:52 EST news163095683 Four risk factors that help predict how long men may survive with metastatic prostate cancer could help doctors choose more effective treatments, according to a study led by researchers in the Duke Comprehensive Cancer Center. http://www.physorg.com/news161546633.html Medicine & Health Thu, 14 May 2009 19:04:16 EST news161546633 (AP) -- Two big prostate cancer studies were intended to settle the question of whether screening for the disease really does save lives. Now the long-awaited results are in - but the debate goes on. http://www.physorg.com/news156597154.html Medicine & Health Wed, 18 Mar 2009 12:16:15 EST news156597154 Women who have more years of fertility (the time from first menstruation to menopause) have a lower risk of developing Parkinson`s disease than women with fewer years, according to a large, new study by researchers at Albert Einstein College of Medicine of Yeshiva University. http://www.physorg.com/news154803926.html Medicine & Health Wed, 25 Feb 2009 17:07:41 EST news154803926 Breast-cancer rates fell steeply and swiftly among postmenopausal women who quit combination hormones in 2002 after warnings about its potential hazards. http://www.physorg.com/news153063400.html Medicine & Health Thu, 05 Feb 2009 13:37:02 EST news153063400 Postmenopausal women who take combined estrogen plus progestin menopausal hormone therapy for at least five years double their annual risk of breast cancer, according to new analyses from a major study that clearly establishes a link between hormone use and breast cancer, Stanford researchers say. The multi-center study also found that women on hormones can quickly reduce their risks of cancer simply by stopping the therapy. http://www.physorg.com/news152993944.html Medicine & Health Wed, 04 Feb 2009 18:19:34 EST news152993944 Two new studies show that commonly prescribed forms of postmenopausal hormone therapy may slightly accelerate the loss of brain tissue in women 65 and older beyond what normally occurs with aging. http://www.physorg.com/news151001109.html Medicine & Health Mon, 12 Jan 2009 16:45:09 EST news151001109 Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests. http://www.physorg.com/news146843957.html Medicine & Health Tue, 25 Nov 2008 13:59:17 EST news146843957 (PhysOrg.com) -- Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests. http://www.physorg.com/news146760397.html Medicine & Health Mon, 24 Nov 2008 14:46:37 EST news146760397 A new Fox Chase Cancer Center study suggests men with early stage prostate cancer treated with radiation therapy should begin hormone therapy immediately if their PSA level rises quickly and doubles within six months at any time after treatment. The study also supports foregoing hormones if the PSA doesn't rise as quickly. Both findings suggest a change in the practice of prescribing hormones is warranted. http://www.physorg.com/news141396110.html Medicine & Health Tue, 23 Sep 2008 13:41:50 EST news141396110 For men with locally advanced prostate cancer the addition of radiation treatment to anti-androgen hormone therapy reduces the risk of dying of prostate cancer by 50 percent compared to those who have anti-androgen hormone treatment alone, according to a randomized study presented September 22, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston. http://www.physorg.com/news141288716.html Medicine & Health Mon, 22 Sep 2008 07:51:56 EST news141288716 Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for Cancer Research. http://www.physorg.com/news134885708.html Medicine & Health Thu, 10 Jul 2008 05:15:08 EST news134885708 Difficulty falling asleep and staying asleep increase as women go through menopause according to research by Rush University Medical Center. Waking up earlier than planned also increases through late perimenopause but decreases when women become postmenopausal. The study is published in the July 1 issue of the journal SLEEP. http://www.physorg.com/news134135697.html Medicine & Health Tue, 01 Jul 2008 12:54:57 EST news134135697